SCHEMBL1010155

SCHEMBL1010155

CN(C)C(=O)CBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27817135 0.97
SCHEMBL21765665 0.80 TRPA1 (0.44)
SCHEMBL4056869 0.75
SCHEMBL22160249 0.75 TRPA1 (0.40)
SCHEMBL68171 0.73
SCHEMBL13913499 0.73
SCHEMBL1191256 0.72 ALDH1A1 (0.63)
SCHEMBL283475 0.72 ALDH1A1 (0.48)
SCHEMBL1563864 0.71
SCHEMBL7389052 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 867 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4724442-A1 AGONISM-ANTAGONISM IN ENDOSOMAL TLRS BY MODULATING CHEMICAL FEATURES IN 8-OXOPURINE: PROCESS FOR PREPARATION AND APPLICATION THEREOF Council of Scientific and Industrial Research (IN) 2026-04-15 EP claimed
CN-117405800-A Method for simultaneously detecting reduced biological ammonia sulfhydryl compound and oxidized biological ammonia sulfhydryl compound 上海中医药大学 2024-01-16 CN claimed
CN-116768884-A Method for synthesizing zolpidem 湖南大学 2023-09-19 CN claimed
CN-105130985-A Phenanthroindolizidine alkaloid quaternary ammonium salt derivative and preparation and plant virus resisting application thereof UNIV NANKAI 2015-12-09 CN claimed
EP-4747260-A1 MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2026-05-27 EP disclosed
EP-4743447-A1 NOVEL COMPOUNDS FOR THE TREATMENT OF CANCER AND METABOLIC DISEASES Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2026-05-20 EP disclosed
EP-4029868-B1 MCL-1 INHIBITORS GILEAD SCIENCES INC (US) 2026-05-20 EP disclosed
EP-4743178-A1 NOVEL COMPOUNDS FOR THE TREATMENT OF CANCER AND METABOLIC DISEASES Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2026-05-20 EP disclosed
EP-4743453-A1 MODULATORS OF MITOCHONDRIAL DNA REPLICATION Pretzel Therapeutics, Inc. (US) 2026-05-20 EP disclosed
CN-122032138-A Composite extract, application thereof and method for extracting plasticizer from polymer 中国石油化工股份有限公司 2026-05-15 CN disclosed
CN-122036504-A Ternary extract, application thereof and method for extracting citrate from polymer 中国石油化工股份有限公司 2026-05-15 CN disclosed
US-12617795-B2 Substituted 6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidines, 5,7-dihydrofuro[3,4-d]pyrimidines, and pyrido[2,3-d]pyrimidines as KCC2 modulators ASTRAZENECA AB (SE) 2026-05-05 US disclosed
EP-0138403-A2 Process for preparing phosphinic acid intermediates E.R. Squibb &amp; Sons, Inc. (US) 1985-04-24 EP disclosed
EP-0127930-A2 Aminocyclopentane esters and their preparation and pharmaceutical formulation GLAXO GROUP LIMITED (GB) 1984-12-12 EP disclosed
EP-0095192-A2 Tetrahydrophthalimides, and their production and use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1983-11-30 EP disclosed
EP-0065374-A1 Substituted phosphinates and phosphinothioates and their use for the control of weeds ZOECON CORPORATION (US) 1982-11-24 EP disclosed
US-4021472-A ANTIPLASMIN AND ANTITRYPSIN ONO PHARMACEUTICAL CO., LTD. (JA) 1977-05-03 US disclosed
US-4004026-A Dicarboxylic acids and derivatives in the treatment of pain and inflammation CIBA-GEIGY CORPORATION (US) 1977-01-18 US disclosed
US-3974284-A 1,1A,6,10B-Tetrahydro-1,6-methano-dibenzo[a,e]cyclopropa[c]cycloheptenes as antidepressants CIBA-GEIGY CORPORATION (US) 1976-08-10 US disclosed
US-3940434-A ANTIINFLAMMATORY, ANALGESIC CIBA-GEIGY CORPORATION (US) 1976-02-24 US disclosed